HNB
CTKB icon

Huntington National Bank’s Cytek Biosciences CTKB Stock Holding History

Huntington National Bank’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-81
Closed -$281 – 4142
2025
Q3 		$281 Hold
81
– – ﹤0.01% 2493
2025
Q2 		$275 Buy
+81
New +$270 ﹤0.01% 2548
2024
Q3 		– Sell
-36
Closed -$201 – 4160
2024
Q2 		$201 Buy
+36
New +$216 ﹤0.01% 2603
2023
Q3 		– Sell
-165
Closed -$1.41K – 3850
2023
Q2 		$1.41K Buy
+165
New +$1.48K ﹤0.01% 2106

Other funds holding CTKB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Huntington National Bank's CTKB Position: Q4 2025 in Review

Huntington National Bank sold out of Cytek Biosciences (CTKB) in Q4 2025, closing a stake of 81 shares — an estimated $281 sold.

Huntington National Bank first reported a position in CTKB in Q2 2023 and held it in 4 quarters. The position peaked at $1.41K in Q2 2023. 155 funds tracked by Wall St. Rank hold CTKB as of Q4 2025.

  • Huntington National Bank reported no remaining Cytek Biosciences position as of Q4 2025 after selling out during the quarter.
  • Huntington National Bank sold 81 Cytek Biosciences shares in Q4 2025, an estimated $281.
  • Huntington National Bank first reported a position in Cytek Biosciences in Q2 2023 and held it in 4 quarters.
  • Huntington National Bank's Cytek Biosciences position peaked at $1.41K in Q2 2023.
  • 155 funds tracked by Wall St. Rank held Cytek Biosciences as of Q4 2025.

Based on Huntington National Bank's 13F filing for Q4 2025, filed 9 Feb 2026.